<PAGE>
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WAHSINGTON D.C. 20549
SCHEDULE 13G
Under the Securities Exchange Act of 1934
Amendment No:
Name of Issuer: Miravant Medical Technologies
Title of Class of Securities: Common Stock
CUSIP Number: 604690 10 7
Check the following box if a fee is being paid with this statement [ ]. (A fee
is not required only if the filing person: (1) has a previous statement on file
reporting beneficial ownership of more than five percent of the class of
securities described in Item 1; and (2) has filed no amendment subsequent
thereto reporting beneficial ownership of five percent or less of such class.)
(See Rule 13d-7).
*The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter the
disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).
CUSIP No. : 604690 10 7
1. NAME OF REPORTING PERSON
S.S OR I.R.S. IDENTIFICATION NO. OF THE ABOVE PERSON
Gary S. Kledzik
SS#: ###-##-####
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP:
(a) [ ]
(b) [ ]
3. SEC USE ONLY
4. CITIZENSHIP OR PLACE OF ORGANIZATION
United States
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH:
5. SOLE VOTING POWER
1,444,125 shares
6. SHARED VOTING POWER
None
7. SOLE DISPOSITIVE POWER
1,444,125 shares
8. SHARED DISPOSITIVE POWER
None
9. AGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
1,444,125 shares
10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*
11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
9.91%
12. TYPE OF REPORTING PERSON*
Gary S. Kledzik - IN
Item 1 (a) Name of Issuer:
Miravant Medical Technologies
Item 1 (b) Address of Issuer's Principal Executive Offices:
7408 Hollister Avenue
Santa Barbara, CA 93117
Item 2 (a) Name of Person Filing:
Gary S. Kledzik
Item 2 (b) Address of Principal Business Office or, if none, Residence:
7408 Hollister Ave., Santa Barbara, CA 93117
Item 2 (c) Citizenship:
United States
Item 2 (d) Title of Class of Securities:
Common Stock
Item 2 (e) CUSIP Number:
604690 10 7
Item 3 (a) If this statement is file pursuant to Rule 13d-1(b), or
13d-2(b), check whether the person filing is a:
Not applicable
Item 4 (a) Amount beneficially owned:
1,444,125 shares
Item 4 (b) Percent of class:
9.91%
Item 4 (c) Number of shares as to which such person has:
(i) sole power to vote or to direct the vote:
1,444,125 shares
(ii) shared power to vote or to direct the vote:
None
(iii) sole power to dispose or to direct the disposition of:
1,444,125 shares
(iv) shared power to dispose or to direct the disposition of:
None
Item 5 Ownership of Five Percent or Less of a Class:
[X] Not Applicable
[ ] This statement is being filed to report the fact that as of
the date hereof the reporting person has ceased to be the
beneficial owner of more than five percent of the class of
securities.
Item 6 Ownership of More than Five Percent on Behalf of Another Person:
[X] Not Applicable
Item 7 Identification and Classification of the Subsidiary Which Acquired
the Security Being Reported on By the Parent Holding Company:
[X] Not Applicable
Item 8 Identification and Classification of Members of the Group:
[X] Not Applicable
Item 9 Notice of Dissolution of Group:
[X] Not Applicable
Item 10 Certification:
[X] Not Applicable
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete
and correct.
Dated: February 11 , 1997
By: /s/ Gary S. Kledzik
----------------------
Gary S. Kledzik
